Skip to main content
Erschienen in:

21.10.2021 | Original Article

Transrectal ultrasound-guided prostate needle biopsy remains a safe method in confirming a prostate cancer diagnosis: a multicentre Australian analysis of infection rates

verfasst von: Cameron J. Parkin, Daniel Gilbourd, Richard Grills, Sue Chapman, Sydney Weinstein, Neil Joshi, Balasubramaniam Indrajit, Jonathan Kam, Teresa Smilovic, Andrew Shepherd, Njeri Gikenye, Mark W. Louie-Johnsun

Erschienen in: World Journal of Urology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Worldwide, transrectal ultrasound-guided prostate needle remains the most common method of diagnosing prostate cancer. Due to high infective complications reported, some have suggested it is now time to abandon this technique in preference of a trans-perineal approach. The aim of this study was to report on the infection rates following transrectal ultrasound-guided prostate needle biopsy in multiple Australian centres.

Materials and methods

Data were collected from seven Australian centres across four states and territories that undertake transrectal ultrasound-guided prostate needle biopsies for the diagnosis of prostate cancer, including major metropolitan and regional centres. In four centres, the data were collected prospectively. Rates of readmissions due to infection, urosepsis resulting in intensive care admission and mortality were recorded.

Results

12,240 prostate biopsies were performed in seven Australian centres between July 1998 and December 2020. There were 105 readmissions for infective complications with rates between centres ranging from 0.19 to 2.60% and an overall rate of 0.86%. Admission to intensive care with sepsis ranged from 0 to 0.23% and overall 0.03%. There was no mortality in the 12,240 cases.

Conclusion

Infective complications following transrectal ultrasound-guided prostate needle biopsies are very low, occurring in less than 1% of 12,240 biopsies. Though this study included a combination of both prospective and retrospective data and did not offer a comparison with a trans-perineal approach, TRUS prostate biopsy is a safe means of obtaining a prostate cancer diagnosis. Further prospective studies directly comparing the techniques are required prior to abandoning TRUS based upon infectious complications.
Literatur
1.
Zurück zum Zitat Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10(2):63–89CrossRef Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10(2):63–89CrossRef
2.
Zurück zum Zitat Torre L, Siegel R, Ward E et al (2016) Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomarkers Prev 25(1):16–27CrossRef Torre L, Siegel R, Ward E et al (2016) Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomarkers Prev 25(1):16–27CrossRef
3.
Zurück zum Zitat Silvaraman A, Sanchez-Salas R, Castro-Marin M et al (2016) Evolution of prostate biopsy techniques. Looking back on a meaningful journey. Actas Urol Esp 40:492–498CrossRef Silvaraman A, Sanchez-Salas R, Castro-Marin M et al (2016) Evolution of prostate biopsy techniques. Looking back on a meaningful journey. Actas Urol Esp 40:492–498CrossRef
4.
Zurück zum Zitat Stefanova V, Buckley R, Flax S et al (2019) Transperineal prostate biopsies using local anesthesia: experience with 1287 patients. Prostate cancer detection rate, complications and patient tolerability. J Urol 201(6):1121–1126CrossRef Stefanova V, Buckley R, Flax S et al (2019) Transperineal prostate biopsies using local anesthesia: experience with 1287 patients. Prostate cancer detection rate, complications and patient tolerability. J Urol 201(6):1121–1126CrossRef
6.
Zurück zum Zitat Mottet N, van den Bergh R, Briers E et al (2021) EAU - ESTRO - ESUR - SIOG guielines on prostate cancer. In: Presented at the EAU annual congress Milan 2021, 978-94-92671-13-4. EAU Guidelines Office, Arnhem, The Netherlands Mottet N, van den Bergh R, Briers E et al (2021) EAU - ESTRO - ESUR - SIOG guielines on prostate cancer. In: Presented at the EAU annual congress Milan 2021, 978-94-92671-13-4. EAU Guidelines Office, Arnhem, The Netherlands
7.
Zurück zum Zitat Loeb S, Vellekoop A, Ahmed H et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64:876–892CrossRef Loeb S, Vellekoop A, Ahmed H et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64:876–892CrossRef
8.
Zurück zum Zitat Tamhankar A, El-Taji O, Vasdev N et al (2020) The clinical and financial implications of a decade of prostate biopsies in the NHS: analysis of Hospital Episode Statistics data 2008–2019. BJU Int 126:133–141CrossRef Tamhankar A, El-Taji O, Vasdev N et al (2020) The clinical and financial implications of a decade of prostate biopsies in the NHS: analysis of Hospital Episode Statistics data 2008–2019. BJU Int 126:133–141CrossRef
9.
Zurück zum Zitat Young R, Norris B, Reeves F et al (2019) A retrospective comparison of transrectal and transperineal prostate biopsies: experience of a single surgeon. J Endourol 33(6):498–502CrossRef Young R, Norris B, Reeves F et al (2019) A retrospective comparison of transrectal and transperineal prostate biopsies: experience of a single surgeon. J Endourol 33(6):498–502CrossRef
11.
Zurück zum Zitat Shen P, Zhu Y, Wei W et al (2012) The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis. Asian J Androl 14(2):310–315CrossRef Shen P, Zhu Y, Wei W et al (2012) The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis. Asian J Androl 14(2):310–315CrossRef
12.
Zurück zum Zitat Hara R, Jo Y, Kondo N et al (2008) Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology 71(2):191–195CrossRef Hara R, Jo Y, Kondo N et al (2008) Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology 71(2):191–195CrossRef
13.
Zurück zum Zitat Pilatz A, Dimitropoulos K, Veeratterapillay R et al (2020) Antibiotic prophylaxis for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis. J Urol 204(2):224–230CrossRef Pilatz A, Dimitropoulos K, Veeratterapillay R et al (2020) Antibiotic prophylaxis for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis. J Urol 204(2):224–230CrossRef
15.
Zurück zum Zitat Leahy O, O’Reilly M, Dyer D et al (2015) Transrectal ultrasound-guided biopsy sepsis and the rise in carbapenem antibiotic use. ANZ J Surg 85:931–935CrossRef Leahy O, O’Reilly M, Dyer D et al (2015) Transrectal ultrasound-guided biopsy sepsis and the rise in carbapenem antibiotic use. ANZ J Surg 85:931–935CrossRef
16.
Zurück zum Zitat Nam R, Saskin R, Lee Y et al (2013) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189(1 Suppl):S12-17PubMed Nam R, Saskin R, Lee Y et al (2013) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189(1 Suppl):S12-17PubMed
17.
Zurück zum Zitat Xue J, Qin Z, Cai H et al (2017) Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis. Oncotarget 8(14):23322–23336CrossRef Xue J, Qin Z, Cai H et al (2017) Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis. Oncotarget 8(14):23322–23336CrossRef
18.
Zurück zum Zitat Wei T, Lin T, Chang Y et al (2015) Transrectal ultrasound-guided prostate biopsy in Taiwan: a nationwide database study. J Chin Med Assoc 78:662–665CrossRef Wei T, Lin T, Chang Y et al (2015) Transrectal ultrasound-guided prostate biopsy in Taiwan: a nationwide database study. J Chin Med Assoc 78:662–665CrossRef
19.
Zurück zum Zitat Roth H, Millar J, Cheng A et al (2015) The state of TRUS biopsy sepsis: readmissions to Victorian hospitals with TRUS biopsy-related infection over 5 years. BJU Int 2015:49–53CrossRef Roth H, Millar J, Cheng A et al (2015) The state of TRUS biopsy sepsis: readmissions to Victorian hospitals with TRUS biopsy-related infection over 5 years. BJU Int 2015:49–53CrossRef
20.
Zurück zum Zitat Patel U, Dasgupta P, Amoroso P et al (2012) Infection after transrectal ultrasonography guided prostate biopsy: increased relative risks after recent international travel or antibiotic use. BJU Int 109:1785–1786CrossRef Patel U, Dasgupta P, Amoroso P et al (2012) Infection after transrectal ultrasonography guided prostate biopsy: increased relative risks after recent international travel or antibiotic use. BJU Int 109:1785–1786CrossRef
21.
Zurück zum Zitat Cussans A, Somani B, Basarab A (2016) The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review. BJU Int 117:725–731CrossRef Cussans A, Somani B, Basarab A (2016) The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review. BJU Int 117:725–731CrossRef
22.
Zurück zum Zitat Ghosh A, Oliver R, Way C et al (2017) Results of day-case ureteroenoscopy (DC-URS) for stone disease: prospective outcomes over 4.5 years. World J Urol 35:1757–1764CrossRef Ghosh A, Oliver R, Way C et al (2017) Results of day-case ureteroenoscopy (DC-URS) for stone disease: prospective outcomes over 4.5 years. World J Urol 35:1757–1764CrossRef
23.
Zurück zum Zitat Palmisano F, Boeri L, Fontana M et al (2018) Incidence and predictors of readmission within 30 days of transurethral resection of the prostate: a single center European experience. Sci Rep 8:6575–6577CrossRef Palmisano F, Boeri L, Fontana M et al (2018) Incidence and predictors of readmission within 30 days of transurethral resection of the prostate: a single center European experience. Sci Rep 8:6575–6577CrossRef
24.
Zurück zum Zitat Losa A, Gadda G, Lazzeri M et al (2013) Complicatoins and quality of life after template-assisted transperineal prostate biopsy in patients eligible for focal therapy. Urology 81:1291–1296CrossRef Losa A, Gadda G, Lazzeri M et al (2013) Complicatoins and quality of life after template-assisted transperineal prostate biopsy in patients eligible for focal therapy. Urology 81:1291–1296CrossRef
25.
Zurück zum Zitat Pepe P, Aragona F (2013) Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. Urology 81:1142–1146CrossRef Pepe P, Aragona F (2013) Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. Urology 81:1142–1146CrossRef
26.
Zurück zum Zitat Berry B, Parry M, Sujenthiran A et al (2020) Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study. BJU Int 126(1):97–103CrossRef Berry B, Parry M, Sujenthiran A et al (2020) Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study. BJU Int 126(1):97–103CrossRef
27.
Zurück zum Zitat Aktas B, Bulut S, Gokkaya C et al (2014) Association of prostate volume with voiding impairment and deterioration in quality of life after prostate biopsy. Urology 83:617–621CrossRef Aktas B, Bulut S, Gokkaya C et al (2014) Association of prostate volume with voiding impairment and deterioration in quality of life after prostate biopsy. Urology 83:617–621CrossRef
29.
Zurück zum Zitat Chrisofos M, Papatsoris A, Dellis A et al (2006) Can prostate biopsies affect erectile function? Andrologia 38:79–83CrossRef Chrisofos M, Papatsoris A, Dellis A et al (2006) Can prostate biopsies affect erectile function? Andrologia 38:79–83CrossRef
30.
Zurück zum Zitat Luong B, Danforth T, Visnjevac O et al (2015) Reduction in hospital admission with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies. Urology 85(3):511–516CrossRef Luong B, Danforth T, Visnjevac O et al (2015) Reduction in hospital admission with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies. Urology 85(3):511–516CrossRef
31.
Zurück zum Zitat Liss M, Ehdaie B, Loeb S et al (2017) An update of the American urological association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol 198(2):329–334CrossRef Liss M, Ehdaie B, Loeb S et al (2017) An update of the American urological association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol 198(2):329–334CrossRef
32.
Zurück zum Zitat Kam J, Yuminaga Y, Kim R et al (2018) Does magnetic resonance imaging-guided biopsy improve prostate cancer detection? A comparison of systematic, cognitive fusion and ultrasound fusion prostate biopsy. Prostate Int 6(3):88–93CrossRef Kam J, Yuminaga Y, Kim R et al (2018) Does magnetic resonance imaging-guided biopsy improve prostate cancer detection? A comparison of systematic, cognitive fusion and ultrasound fusion prostate biopsy. Prostate Int 6(3):88–93CrossRef
33.
Zurück zum Zitat Rapisarda S, Bada M, Crocetto F et al (2020) The role of multiparametric resonance and biopsy in prostate cancer detection: comparison with definitive histological report after laparoscopic/robotic radical prostatectomy. Abdom Radiol 45:4178–4184CrossRef Rapisarda S, Bada M, Crocetto F et al (2020) The role of multiparametric resonance and biopsy in prostate cancer detection: comparison with definitive histological report after laparoscopic/robotic radical prostatectomy. Abdom Radiol 45:4178–4184CrossRef
34.
Zurück zum Zitat Altok M, Kim B, Patel B et al (2018) Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research. Prostate Cancer Prostate Dis 21:524–532CrossRef Altok M, Kim B, Patel B et al (2018) Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research. Prostate Cancer Prostate Dis 21:524–532CrossRef
Metadaten
Titel
Transrectal ultrasound-guided prostate needle biopsy remains a safe method in confirming a prostate cancer diagnosis: a multicentre Australian analysis of infection rates
verfasst von
Cameron J. Parkin
Daniel Gilbourd
Richard Grills
Sue Chapman
Sydney Weinstein
Neil Joshi
Balasubramaniam Indrajit
Jonathan Kam
Teresa Smilovic
Andrew Shepherd
Njeri Gikenye
Mark W. Louie-Johnsun
Publikationsdatum
21.10.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 2/2022
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-021-03862-8

Neu im Fachgebiet Urologie

Wechsel von Zugangsroute und Biopsiesteuerung: Erfahrungen eines Zentrums

Geht der Switch zur transperinealen gezielten Prostatabiopsie auf Kosten der diagnostischen Qualität? Nein, urteilen norwegische Urologinnen und Urologen nach Durchsicht von Daten aus ihrer Einrichtung.

Warum werden Hodenprothesen so selten angeboten?

Forschende aus Großbritannien haben untersucht, wie häufig eine Hodenprothese bei krebsbedingter radikaler Orchidektomie angeboten wird. Vor allem die Gründe, warum kein Implantat zur Wahl gestellt wird, sind erstaunlich. 

Genügt die biparametrische MRT für die Prostatadiagnostik?

Die multiparametrische Magnetresonanztomografie hat einen festen Platz im Screening auf klinisch signifikante Prostatakarzinome. Ob auch ein biparametrisches Vorgehen ausreicht, ist in einer Metaanalyse untersucht worden.

Große Trinkmengen bei Blasentumoren möglicherweise von Nachteil

Beim nicht-muskelinvasiven Blasenkrebs scheint eine hohe Flüssigkeitszufuhr keinen schützenden Effekt in Bezug auf das Risiko eines Rezidivs oder einer Krankheitsprogression zu haben. Eine niederländische Studie legt sogar nahe, dass große Trinkmengen das Fortschreiten der Erkrankung begünstigen könnten.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.